Breast Various Pathology Developmental Process Tissue Array, Including TNM And Pathology Grade, 71 Cases/72 Cores|ヒト組織アレイ

掲載日情報:2015/08/07 現在Webページ番号:172887

US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Breast Various Pathology Developmental Process Tissue Array, Including TNM And Pathology Grade, 71 Cases/72 Cores)をご紹介します。

ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
本製品は研究用です。研究用以外には使用できません。

ヒト組織アレイの価格

[在庫・価格 :2024年06月05日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Breast various pathology developmental process tissue array, including TNM and pathology grade, 71 cases/72 cores
2~3週間 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0

[在庫・価格 :2024年06月05日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Breast various pathology developmental process tissue array, including TNM and pathology grade, 71 cases/72 cores

文献数: 0

目次に戻る

ヒト組織アレイの特長

Microarray Panel: Breast various pathology developmental process tissue microarray, containing 3 adjacent normal tissue, 2 normal tissue, 9 adenosis, 4 adenoma, 18 hyperplasia, 3 intraductal carcinoma, 18 invasive ductal carcinoma, 3 medullary carcinoma, 3 mucinous carcinoma, 3 lobular carcinoma, 6 metastatic carcinoma, single core per case
Cores: 72
組織アレイ
Cases: 71
Layout: 9 cols × 8 rows
Core Diameter: 1.5 mm
Thickness: 5 µm
Applications:

Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.

Notes: Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H and E: Hematoxylin and Eosin stained tissue array slide.

目次に戻る

ヒト組織アレイの仕様表

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 42 Breast Cancer adjacent normal breast tissue NAT
A2 2 F 40 Breast Cancer adjacent normal breast tissue NAT
A3 3 F 44 Breast Cancer adjacent normal breast tissue NAT
A4 4 F 21 Breast Normal breast tissue (sparse) Normal
A5 5 F 18 Breast Normal breast duct tissue Normal
A6 6 F 39 Breast Adenosis (sparse) Benign
A7 7 F 40 Breast Adenosis Benign
A8 8 F 35 Breast Adenosis Benign
A9 9 F 41 Breast Adenosis (fibrofatty tissue) Benign
B1 10 F 37 Breast Adenosis Benign
B2 11 F 34 Breast Adenosis Benign
B3 12 F 48 Breast Adenosis Benign
B4 13 F 61 Breast Adenosis (fibrofatty tissue) Benign
B5 14 F 42 Breast Adenosis Benign
B6 15 F 22 Breast Fibroadenoma Benign
B7 16 F 28 Breast Fibroadenoma Benign
B8 17 F 42 Breast Fibroadenoma Benign
B9 18 F 35 Breast Fibroadenoma Benign
C1 19 F 44 Breast Hyperplasia of lobule Benign
C2 20 F 18 Breast Hyperplasia of lobule Benign
C3 21 F 45 Breast Hyperplasia of lobule Benign
C4 22 F 23 Breast Hyperplasia of lobule Benign
C5 23 F 47 Breast Adenosis with mild hyperplasia of ductal epithelium Benign
C6 24 F 50 Breast Hyperplasia (fibrofatty tissue) Benign
C7 25 F 45 Breast Mild hyperplasia of ductal epithelium Benign
C8 26 F 54 Breast Papillary hyperplasia of ductal epithelium Benign
C9 27 F 42 Breast Hyperplasia (fibrous tissue and blood vessel tissue) Benign
D1 28 F 48 Breast Mild atypical hyperplasia of lobular epithelium (sparse) Benign
D2 29 F 52 Breast Mild atypical hyperplasia of lobular epithelium Benign
D3 30 F 38 Breast Mild atypical hyperplasia of lobular epithelium (sparse) Benign
D4 31 F 48 Breast Mild atypical hyperplasia of ductal epithelium Benign
D5 32 F 45 Breast Mild atypical hyperplasia of lobular epithelium Benign
D6 33 F 45 Breast Moderate atypical hyperplasia of ductal epithelium Benign
D7 34 F 46 Breast Hyperplasia (fibrofatty tissue) Benign
D8 35 F 50 Breast Mild atypical hyperplasia of lobular epithelium Benign
D9 36 F 40 Breast Mild atypical hyperplasia of lobular epithelium Benign
E1 37 F 32 Breast Intraductal carcinoma I T1N0M0 Malignant
E2 38 F 41 Breast Intraductal carcinoma 0 TisN0M0 Malignant
E3 39 F 54 Breast Intraductal carcinoma IIa T2N0M0 Malignant
E4 40 F 33 Breast Invasive ductal carcinoma 1 IIa T2N0M0 Malignant
E5 41 F 52 Breast Invasive ductal carcinoma 2 IIIb T4cN0M0 Malignant
E6 42 F 48 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
E7 43 F 39 Breast Invasive ductal carcinoma 2 I T1N0M0 Malignant
E8 44 F 40 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
E9 45 F 50 Breast Invasive ductal carcinoma (adenosis) 2 IIa T2N0M0 Malignant
F1 46 F 41 Breast Invasive ductal carcinoma IIa T2N0M0 Malignant
F2 47 F 27 Breast Invasive ductal carcinoma 2 IIb T2N1M0 Malignant
F3 48 F 39 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
F4 49 F 31 Breast Invasive ductal carcinoma 2 IIb T3N1M0 Malignant
F5 50 F 42 Breast Invasive ductal carcinoma (sparse) IIa T2N0M0 Malignant
F6 51 F 45 Breast Invasive ductal carcinoma 1–2 IV T3N1M1 Malignant
F7 52 F 54 Breast Invasive ductal carcinoma 2 IIa T2N0M0 Malignant
F8 53 F 49 Breast Invasive ductal carcinoma 3 IIa T2N0M0 Malignant
F9 54 F 36 Breast Invasive ductal carcinoma 3 IIa T2N0M0 Malignant
G1 55 F 53 Breast Invasive ductal carcinoma 3 IIIb T4N1M0 Malignant
G2 56 F 30 Breast Invasive ductal carcinoma 3 IIa T2N0M0 Malignant
G3 57 F 50 Breast Invasive ductal carcinoma 3 IIa T2N0M0 Malignant
G4 58 F 64 Breast Medullary carcinoma IIa T2N0M0 Malignant
G5 59 F 59 Breast Medullary carcinoma I T1N0M0 Malignant
G6 60 F 57 Breast Medullary carcinoma I T1N0M0 Malignant
G7 61 F 83 Breast Mucinous carcinoma IIa T2N0M0 Malignant
G8 62 F 70 Breast Mucinous carcinoma I T1N0M0 Malignant
G9 63 F 67 Breast Mucinous carcinoma I T1N0M0 Malignant
H1 64 F 50 Breast Invasive lobular carcinoma IIa T2N0M0 Malignant
H2 65 F 51 Breast Invasive lobular carcinoma IIIb T4N0M0 Malignant
H3 66 F 53 Breast Invasive lobular carcinoma IIIb T4N1M0 Malignant
H4 67 F 56 Lymhp node Metastatic invasive ductal carcinoma from breast Metastasis
H5 68 F 47 Lymhp node Metastatic invasive ductal carcinoma from breast Metastasis
H6 69 F 39 Lymhp node Metastatic invasive ductal carcinoma from breast Metastasis
H7 70 F 52 Lymhp node Metastatic invasive ductal carcinoma from breast Metastasis
H8 71 F 51 Lymhp node Metastatic invasive ductal carcinoma from breast Metastasis
H9 72 F 57 Lymhp node Metastatic invasive ductal carcinoma from breast Metastasis
F 55 liver Hepatocellular liver cancer (tissue marker) 3 T3N0M0 Malignant

*For precise diagnosis, refer to pathology description.

目次に戻る

ヒト組織アレイのFAQ

目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。